Health Sciences Group, Inc. (HESG)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 11, 2026
Health Sciences Group Market Cap
Health Sciences Group has a market cap or net worth of $20.51 thousand as of February 13, 2026.
Market Cap
20.51K
Enterprise Value
n/a
Revenue
69.31K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 3, 2001, Health Sciences Group's market cap has decreased from 2.39M to 20.51K, a decrease of -99.14%. That is a compound annual growth rate of -17.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 20.51K | - |
| Dec 30, 2025 | 20.51K | - |
| Dec 31, 2024 | 20.51K | - |
| Dec 29, 2023 | 20.51K | - |
| Dec 30, 2022 | 20.51K | - |
| Dec 31, 2021 | 20.51K | -99.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Statera Biopharma | 29.03K |
| Scopus BioPharma | 25.25K |
| Scorpius Holdings | 24.46K |
| ObsEva | 23.44K |
| Syros Pharmaceuticals | 21.47K |
| America Great Health | 21.15K |
| Regenicin | 15.35K |
| Virpax Pharmaceuticals | 13.30K |